NasdaqCM - Nasdaq Real Time Price • USD
Brainstorm Cell Therapeutics Inc. (BCLI)
As of 11:47 AM EDT. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 9.06M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.53 - 0.55 per share. | Direct | 131,411 | Apr 18, 2024 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2024 |
YABLONKA URI Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2024 |
PATLIS ALLA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2024 |
LINDBORG STACY R. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 11, 2024 |
LINDBORG STACY R. PH.D. Chief Executive Officer | Purchase at price 1.77 per share. | Direct | 20,402 | Sep 1, 2023 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 2, 2023 |
LINDBORG STACY R. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 2, 2023 |
NAOR NIR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 19, 2023 |
TAYLOR KIRK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 1, 2023 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 20, 2023 |
LINDBORG STACY R. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 20, 2023 |
LINDBORG STACY R. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 7, 2022 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 16, 2022 |
KERN RALPH DR. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2022 |
POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2022 |
TAUB MALCOLM S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 15, 2021 |
ALMENOFF JUNE SHERIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 15, 2021 |
POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 15, 2021 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
TAUB MALCOLM S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
ALMENOFF JUNE SHERIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
KERN RALPH DR. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
ABBHI SANKESH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 10, 2021 |
WACLAWSKI ANTHONY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 8, 2020 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 24, 2020 |
ACC INTERNATIONAL HOLDINGS LTD Beneficial Owner of more than 10% of a Class of Security | Sale at price 13.12 - 13.52 per share. | Direct | 960,656 | Jul 16, 2020 |
SETBOUN DAVID Chief Operating Officer | Purchase at price 12.95 per share. | Direct | 64,740 | Jul 16, 2020 |
ABBHI SANKESH Director | Purchase at price 12.99 per share. | Indirect | 607,659 | Jul 15, 2020 |
YABLONKA URI Officer and Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 23, 2020 |
LINDBORG STACY R. PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2020 |
SETBOUN DAVID Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 7, 2020 |
ABBHI SANKESH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 6, 2020 |
KERN RALPH DR. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2020 |
POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2020 |
ARAYA ARTURO Officer | Purchase at price 3.90 per share. | Direct | 11,700 | Dec 24, 2019 |
KERN RALPH DR. Chief Operating Officer | Purchase at price 3.88 per share. | Direct | 11,640 | Dec 24, 2019 |
SHAH PREETAM Chief Financial Officer | Purchase at price 3.96 per share. | Direct | 45,929 | Dec 24, 2019 |
TAUB MALCOLM S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2019 |
ALMENOFF JUNE SHERIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 12, 2019 |
SHAH PREETAM Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 6, 2019 |
ARBEL IRIT Director | Sale at price 3.67 per share. | Direct | 48,891 | Aug 28, 2019 |
ARBEL IRIT Director | Conversion of Exercise of derivative security at price 2.25 per share. | Direct | 29,997 | Aug 28, 2019 |
LEBOVITS CHAIM Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 26, 2019 |
KERN RALPH DR. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2019 |
POLVERINO ANTHONY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2019 |
ALMENOFF JUNE SHERIE Director | Purchase at price 3.39 per share. | Indirect | 5,000 | Jan 4, 2019 |
SCHOR CHEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2018 |
TAUB MALCOLM S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 30, 2018 |
Related Tickers
KTRA Kintara Therapeutics, Inc.
0.1514
+10.28%
BLRX BioLineRx Ltd.
0.5908
-3.61%
AMLX Amylyx Pharmaceuticals, Inc.
1.7950
-4.52%
CLNN Clene Inc.
0.3401
+0.92%
KZIA Kazia Therapeutics Limited
0.3900
+0.26%
RNAZ TransCode Therapeutics, Inc.
0.4698
+6.80%
PBLA Panbela Therapeutics, Inc.
0.4600
+13.48%
PXMD PaxMedica, Inc.
0.7048
+1.85%
MAIA MAIA Biotechnology, Inc.
2.6750
-0.56%
CGTX Cognition Therapeutics, Inc.
1.9000
-4.52%